Definitive Contract HHSN268201100037C
Award Date
6/1/11
Potential Completion Date
2/28/17
Potential Value
$30M
Federal Agency
National Heart Lung and Blood Institute
Awardee
University Of Washington
Ultimate Awardee
University Of Washington
NAICS Category
541712 - Research and Development in the Physical, Engineering, and Life Sciences (except Biotechnology)
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Cost No Fee
Place of Performance
Seattle, WA 98105, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
2
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a prime federal contract award from the National Heart Lung and Blood Institute, a subcomponent of the Department of Health and Human Services, to the University of Washington (UW). The $11,349,244.46 cost-plus-award-fee contract is for the Laboratory Centers for DNA Re-sequencing & Genotyping Program, which provides specialized research and laboratory services. The contract is not set aside for small businesses. UW is a large public research university that frequently secures...
This is a definitive, firm fixed price contract awarded by the National Heart Lung and Blood Institute (NHLBI), a civilian agency, to the University of Washington. The contract, valued at $783,706.00, is for special studies and analysis services. The University of Washington has a history of delivering a range of services to federal agencies, including research and development work. This contract does not have a set-aside designation. The University of Washington also holds a separate $500...
The University of Washington (UW) was awarded a $674,371 delivery order contract by the National Heart, Lung and Blood Institute (NHLBI) to provide biorepository-based research projects under the Cardiovascular Health Study (CHS) Task Area B. This contract has no set-aside designation. UW has a history of securing prime federal contracts, grants, and subcontracts from civilian and defense agencies, leveraging its expertise in research, healthcare, and technical services. UW also holds an...
The University of Washington, doing business as the Northwest Genomics Center, has been awarded a firm fixed price purchase order valued at seventy-two thousand nine hundred sixty-six dollars and fifteen cents ($72,966.15) by the National Heart, Lung and Blood Institute of the National Institutes of Health. Under this contract, the Center will perform high-throughput sequencing of RNAs in three hundred platelet cell samples to support the Institute's research efforts. The work will be...
This is a firm-fixed-price purchase order for $432,005.00 awarded by the Department of Health and Human Services National Institutes of Health National Heart, Lung and Blood Institute to the University of Washington for RNA sequencing services in support of the Framingham Heart Study. The contract has no set-aside designation. The University of Washington is a leading research university that has previously received federal prime contracts and subcontracts for a range of research services,...
This federal contract was awarded by the National Heart Lung and Blood Institute (NHLBI), a component of the National Institutes of Health, to the University of Washington (UW). The contract has a ceiling value of $13,796,600.00 and a period of performance through December 31, 2024. It covers Task Area A, which includes annual follow-up of cohort members, clinical endpoints ascertainment, study coordination, database and biospecimen repository maintenance, and data analysis and manuscript...
This is a firm fixed price purchase order awarded by the National Heart Lung and Blood Institute, a civilian agency within the U.S. Department of Health and Human Services, to the University of Washington. The contract is for $116,617.00 and has an ultimate completion date of September 29, 2017. The award is for a non-R&D project titled "IDENTIFYING COMMENSURATION BIAS IN NIH/CSR PEER REVIEW" and does not have a set-aside designation. The University of Washington is a leading...
This is a $26,116,402.00 definitive cost no fee contract awarded by the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK), a civilian agency, to the University of Washington (UW). The contract is for biomedical (applied/exploratory) services. It does not have a set-aside designation. UW is a leading public research university that leverages its academic and research capabilities to support various federal agencies through contracts and grants. The university often serves...
The University of Washington was awarded a firm fixed-price purchase order in the amount of thirteen thousand one hundred sixty-nine dollars and twenty-six cents ($13,169.26) by the Department of Health and Human Services' National Institutes of Health National Heart, Lung and Blood Institute. The contract is for platelet RNA sequencing services in support of the Framingham Heart Study, with no set-aside designation. Performance will take place in Bethesda, Maryland through September 2020. No...
This federal contract award was issued by the National Heart Lung and Blood Institute (NHLBI), a component of the National Institutes of Health (NIH), to the University of Washington (UW) for "CARDIOVASCULAR HEALTH STUDY - CORE SUPPORT" with a ceiling value of $3,621,668.00. The contract is a definitive contract with a firm fixed price pricing type. No set-aside designation was used. The ultimate completion date for the contract is December 31, 2015. UW has served as both a prime...